Corpus overview


MeSH Disease

HGNC Genes

There are no HGNC terms in the subcorpus

SARS-CoV-2 proteins

There are no SARS-CoV-2 protein terms in the subcorpus


SARS-CoV-2 Proteins
    displaying 1 - 1 records in total 1
    records per page

    An Analysis on the Clinical Features of MHD Patients with Coronavirus Disease 2019 MESHD: A Single Center Study

    Authors: cheng li; Min Yonglong; Tu Can; Mao Dongdong; Wan Sheng; Liu Haifeng; Xiong Fei

    doi:10.21203/ Date: 2020-03-18 Source: ResearchSquare

    Background: In this study, we aimed to find out the features of the maintenance hemodialysis ( MHD MESHD) patients infected with Coronavirus Disease 2019 MESHD ( COVID-19 MESHD) in the Blood Purification Center of Wuhan No.1 Hospital, Hubei Province, China, and provide evidences for clinical treatment.Methods: We collected the data of all the MHD MESHD patients in this hemodialysis center by February 20, 2020, including those infected with COVID-19 MESHD. These patients were divided into three groups: the control group (537 cases), confirmed group (66 cases) and suspected group (24 cases). We compared the relevant data of the three groups and analyzed the factors that may affect the possibility of catching COVID-19 MESHD.Results: 1. By February 20, 2020, there were 627 MHD MESHD patients in the Hemodialysis Center of Wuhan No.1 Hospital. The prevalence rate of the COVID-19 MESHD was 14.35% (90/627, including 66 confirmed cases and 24 suspected cases); the fatality rate 13.33% (12/90, including 12 death MESHD cases); the mortality rate 1.91% (12/627).2. The comparison between the three groups revealed the following results: weekly hemodialysis duration ( WHD MESHD), ultrafiltration volume (UFV) and ultrafiltration rate (UFR) of the confirmed group were obviously lower than those of the control and suspected groups (P<0.05); the neutrophil ratio (N%), neutrophil (N#), monocyte (M#) and total carbon dioxide (TCO2) were significantly higher than those of the control group while the lymphocyte ratio (L%) was much lower (P<0.05).3. The lung CT scans found three common features: bilateral abnormalities (81.54%), multiple abnormalities MESHD (84.62%) and patchy opacity (61.54%).4. The binary logstic regression analysis showed that diabetes MESHD (OR=5.404,95% CI 1.950~14.976, P=0.001) and hypertension MESHD (OR=3.099,95% CI 1.380~6.963, P=0.006) are independent risk factors for MHD MESHD patients to be infected with COVID-19 MESHD; WHD (OR=0.846,95% CI 0.737~0.970, P=0.017), UFR (OR=0.012,95% CI 0.002~0.058, P<0.001) and serum ferritin (SF, OR=0.823,95% CI 0.748~0.906, P<0.001) are independent protective factors.Conclusion: MHD MESHD patients with diabetes MESHD or hypertension MESHD are more likely to be infected with COVID-19 MESHD. In clinical treatment, hemodialysis duration, UFR and SF levels should be controlled appropriately to reduce the risk of infection.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.



MeSH Disease
HGNC Genes
SARS-CoV-2 Proteins

Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.